Adial Pharmaceuticals, Inc. (ADIL)

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.

Current Quote*
Last: $2.050
Change: 0.060
Book: $1.733
Volume: 55,363

As Of: 07/16 12:22 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol ADIL

  • No BuyIns.Net Alerts Available for ADIL

Graphs for ADIL

3 Month Graph

6 Month Graph

1 Year Graph